LyGenesis, Inc.
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Pharmaceuticals
See more in Biomedtracker
Latest on LyGenesis, Inc.
Scrip
• By Mandy Jackson
October ended and November began with the announcement of three new venture capital and equity funds with more than $1.3bn for health care, life science and biopharmaceutical investments. Revelation P
Scrip
• By Joseph Haas, Lisa Takagi, and Dexter Jie Yan
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. SNBL To Pay 28% Premium To Re-Acquire S
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biolojic To Use Computational Platform